SPIMACO’s Moroccan plant to begin trial run in Q4 2019

25/03/2019 Argaam

Saudi Pharmaceutical Industries and Medical Appliances (SPIMACO) expects pilot operations at Morocco’s facility to commence in the fourth quarter of the year.

Electrical and mechanical construction services at the Casablanca-based pharmaceutical plant were completed, SPIMACO said in a bourse statement on Monday.

However, the qualification process was rescheduled to begin in Q3 2019, due to a delay in receiving the required equipment.

The related financial impact will be announced later on, the pharmaceutical producer added.


News

Prices

Aramco IPONew

Sectors

Companies

Financial Data

Financial Ratios

Analysts

IPOs

Economy

Mutual Funds

Projects

Interactive Charts